SERV · Serve Robotics Inc.

Serve Robotics’ acquisition of Diligent Robotics represents a strategic vertical expansion into healthcare robotics, leveraging Diligent’s FDA-cleared Moxi platform for non-patient-facing hospital logistics. The $25.7 million preliminary purchase price—comprising $20.1 million in cash, $2.5 million in Serve common stock (priced at $12.77 per share on the Closing Date), and $3.1 million in milestone-contingent earnout—reflects Serve’s intent to acquire both technology and commercial traction. Diligent’s 2025 financials reveal a nascent but focused business: $9.0 million in revenue, $22.7 million net loss, and only $1.1 million in cash, underscoring its pre-profitability stage and dependence on external funding. The pro forma allocation assigns $11.8 million to goodwill and $6.0 million to identifiable intangible assets (primarily developed technology), indicating Serve’s valuation emphasis on intellectual property and future synergies rather than near-term earnings contribution. Critically, Diligent’s audited financial statements explicitly state substantial doubt about its ability to continue as a going concern—a disclosure that transfers material execution and integration risk to Serve, particularly regarding Diligent’s path to positive cash flow and scalability. The transaction also introduces $1.2 million in estimated non-recurring transaction costs and requires final purchase price allocation within one year, meaning current pro forma figures remain subject to material revision. For investors, this acquisition signals Serve’s commitment to diversifying beyond last-mile delivery into adjacent high-value robotics markets—but also introduces near-term dilution, integration complexity, and heightened liquidity scrutiny given Diligent’s financial profile.